⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2418191 | 0.82 | — | — | |
| SCHEMBL9081365 | 0.81 | — | — | |
| SCHEMBL1706017 | 0.79 | — | — | |
| SCHEMBL1253974 | 0.77 | — | — | |
| SCHEMBL2937278 | 0.77 | — | — | |
| SCHEMBL1706051 | 0.76 | — | — | |
| SCHEMBL6261325 | 0.74 | — | — | |
| SCHEMBL1707051 | 0.74 | — | — | |
| SCHEMBL3868432 | 0.73 | — | — | |
| SCHEMBL5267527 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1351979-B1 | REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS | SMITHKLINE BEECHAM CORP (US) | 2008-01-16 | — | — | EP | claimed |
| EP-1032387-B1 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORP (US) | 2007-03-07 | — | — | EP | claimed |
| EP-1039906-B1 | METAL COMPLEXES WITH ANTIBACTERIAN AND FUNGICIDAL EFFECTS | SMITHKLINE BEECHAM CORP (US) | 2008-02-27 | — | — | EP | disclosed |
| EP-1351979-B1 | REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS | SMITHKLINE BEECHAM CORP (US) | 2008-01-16 | — | — | EP | disclosed |
| EP-1351979-A4 | REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS | SMITHKLINE BEECHAM CORP (US) | 2005-04-27 | — | — | EP | disclosed |
| US-20040053299-A1 | Regulated activation of cell-membrane receptors by metal-chelating agonists | SMITHKLINE BEECHAM CORPORATION | 2004-03-18 | — | — | US | disclosed |
| EP-1032387-A4 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORP (US) | 2004-02-11 | — | — | EP | disclosed |
| EP-1039906-A4 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORP (US) | 2004-02-11 | — | — | EP | disclosed |
| EP-1351979-A1 | REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS | SmithKline Beecham Corporation (US) | 2003-10-15 | — | — | EP | disclosed |
| US-20030013697-A1 | Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal | SMITHKLINE BEECHAM CORPORATION AND LIGAND PHARMACEUTICALS | 2003-01-16 | — | — | US | disclosed |
| EP-1032388-A4 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORP (US) | 2002-10-02 | — | — | EP | disclosed |
| US-20010016568-A1 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORPORATION | 2001-08-23 | — | — | US | disclosed |
| US-20010014454-A1 | NOVEL METAL COMPLEXES | NOVARTIS AG (CH) | 2001-08-16 | — | — | US | disclosed |
| US-6211200-B1 | ADMINISTERING ZINC CHELATED IMIDAZO(4,5-D)IMIDAZOLE COMPOUNDS AS GRANULOCYTE COLONY STIMULATING FACTOR AGONISTS | SMITHKLINE BEECHAM CORPORATION | 2001-04-03 | — | — | US | disclosed |
| EP-1039906-A1 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORPORATION (US) | 2000-10-04 | — | — | EP | disclosed |
| EP-1032388-A1 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORPORATION (US) | 2000-09-06 | — | — | EP | disclosed |
| EP-1032387-A1 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORPORATION (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999022732-A1 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORPORATION (US) | 1999-05-14 | — | — | WO | disclosed |
| WO-1999022733-A1 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORPORATION (US) | 1999-05-14 | — | — | WO | disclosed |
| WO-1999022734-A1 | NOVEL METAL COMPLEXES | SMITHKLINE BEECHAM CORPORATION (US) | 1999-05-14 | — | — | WO | disclosed |